68124 Federal Register / Vol. 88, No. 190 / Tuesday, October 3, 2023 / Notices 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, MPR, Bethesda, MD 

20892–7510. 

Time: December 5, 2023, 9:00 a.m. to 12:30 

p.m. 

Agenda: Science Talk: Insights from a 

Career Studying TBI, Anger, Relationships, 

and Outcome Path; Science Talks: Injury 

Rehabilitation; Planning for Next Board 

Meeting in May 2024. 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, MPR, Bethesda, MD 

20892–7510. 

Contact Person: Ralph M. Nitkin, Ph.D., 

Deputy, National Center for Medical 

Rehabilitation Research and Director, 

Biological Sciences and Career Development 

Program, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2116, 

Bethesda, MD 20892–7510, (301) 402–4206, 

nitkinr@mail.nih.gov. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nichd.nih.gov/about/advisory/nabmrr, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: September 27, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21777 Filed 10–2–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01 Clinical 

Trial Not Allowed). 

Date: November 2, 2023. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G22, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Michael M. Opata, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G22, Rockville, MD 

20852, 240–627–3319, michael.opata@

nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Support for Research 

Excellence (SuRE) Award (R16—Clinical 

Trial Not Allowed). 

Date: November 7, 2023. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G22, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Michael M. Opata, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G22, Rockville, MD 

20852, 240–627–3319, michael.opata@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: September 27, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21768 Filed 10–2–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Advisory Child Health and 

Human Development Council Task 

Force on Research Specific to 

Pregnant Women and Lactating 

Women (PRGLAC) Implementation 

Working Group Meeting 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development (NICHD) PRGLAC 

Implementation Working Group of 

Council is charged with monitoring and 

reporting on implementation of the 

recommendations from the PRGLAC. 

This includes monitoring and reporting 

on implementation, updating 

regulations, and guidance, as applicable, 

regarding the inclusion of pregnant 

women and lactating women in clinical 

trials. 

DATES: The virtual meeting will be held 

on November 17, 2023, from 12 p.m. to 

4 p.m. EST. 

ADDRESSES: The virtual meeting will be 

videocast and can be accessed from the 

NIH Videocasting website at http://

videocast.nih.gov/. 

FOR FURTHER INFORMATION CONTACT: For 

information concerning this meeting, 

Dr. Emma Carpenter, Health Science 

Policy Analyst Office of Legislation and 

Public Policy, NICHD, NIH, 6710B 

Rockledge Drive, Bethesda, MD 20892– 

7510, emma.carpenter@nih.gov, 303– 

981–0855. 

SUPPLEMENTARY INFORMATION: This 

notice is pursuant to 42 U.S.C. 285g. 

The National Advisory Child Health and 

Human Development Council Task 

Force on Research Specific to Pregnant 

Women and Lactating Women 

(PRGLAC) Implementation Working 

Group meeting will be open to the 

public as a virtual meeting. Individuals 

who need special assistance, such as 

sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed in 

advance of the meeting. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nichd.nih.gov/about/advisory, 


ddrumheller on DSK120RN23PROD with NOTICES1